Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wilking

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Lancet (London, England)|October 29, 2000
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 studyJ Bergh, T Wiklund, B Erikstein, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
Strain- and vaccine-specific effects of serum antibodies in the protection of intestinal SARS-CoV-2 infectionM D Cherne, D Snyder, B Sidar, et al.
Nature Communications|October 29, 2023
Antiviral responses in a Jamaican fruit bat intestinal organoid model of SARS-CoV-2 infectionMarziah Hashimi, T Andrew Sebrell, Jodi F Hedges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study GroupJ M Nabholtz, H J Senn, W R Bezwoda, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Lancet (London, England)|October 29, 2000
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 studyJ Bergh, T Wiklund, B Erikstein, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
Strain- and vaccine-specific effects of serum antibodies in the protection of intestinal SARS-CoV-2 infectionM D Cherne, D Snyder, B Sidar, et al.
Nature Communications|October 29, 2023
Antiviral responses in a Jamaican fruit bat intestinal organoid model of SARS-CoV-2 infectionMarziah Hashimi, T Andrew Sebrell, Jodi F Hedges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study GroupJ M Nabholtz, H J Senn, W R Bezwoda, et al.
Pageof 11